Blue rubber bleb nevus syndrome medical therapy: Difference between revisions
| Line 9: | Line 9: | ||
* Preferred regimen (1):[[Interferon-beta]], 1.2 mg/m<sup>2</sup>/day for 2 months | * Preferred regimen (1):[[Interferon-beta]], 1.2 mg/m<sup>2</sup>/day for 2 months | ||
* Preferred regimen (2):[[Octreotide]] | * Preferred regimen (2):[[Octreotide]], 5.7 microg/kg subcutaneously twice daily for 4 weeks<ref name="pmid11568521">{{cite journal |vauthors=Gonzalez D, Elizondo BJ, Haslag S, Buchanan G, Burdick JS, Guzzetta PC, Hicks BA, Andersen JM |title=Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber-bleb nevus syndrome |journal=J. Pediatr. Gastroenterol. Nutr. |volume=33 |issue=2 |pages=183–8 |date=August 2001 |pmid=11568521 |doi= |url=}}</ref> | ||
* Preferred regimen (3):[[Sirolimus]] <ref name="pmid27820137">{{cite journal |vauthors=Ünlüsoy Aksu A, Sari S, Eğritaş Gürkan Ö, Dalgiç B |title=Favorable Response to Sirolimus in a Child With Blue Rubber Bleb Nevus Syndrome in the Gastrointestinal Tract |journal=J. Pediatr. Hematol. Oncol. |volume=39 |issue=2 |pages=147–149 |date=March 2017 |pmid=27820137 |doi=10.1097/MPH.0000000000000681 |url=}}</ref> | * Preferred regimen (3):[[Sirolimus]] <ref name="pmid27820137">{{cite journal |vauthors=Ünlüsoy Aksu A, Sari S, Eğritaş Gürkan Ö, Dalgiç B |title=Favorable Response to Sirolimus in a Child With Blue Rubber Bleb Nevus Syndrome in the Gastrointestinal Tract |journal=J. Pediatr. Hematol. Oncol. |volume=39 |issue=2 |pages=147–149 |date=March 2017 |pmid=27820137 |doi=10.1097/MPH.0000000000000681 |url=}}</ref> | ||
* Preferred regimen (4):[[Iron]] supplementation | * Preferred regimen (4):[[Iron]] supplementation | ||
Revision as of 15:43, 24 January 2019
|
Blue rubber bleb nevus syndrome Microchapters |
|
Differentiating Blue Rubber Bleb Nevus Syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Blue rubber bleb nevus syndrome medical therapy On the Web |
|
American Roentgen Ray Society Images of Blue rubber bleb nevus syndrome medical therapy |
|
Directions to Hospitals Treating Blue rubber bleb nevus syndrome |
|
Risk calculators and risk factors for Blue rubber bleb nevus syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Vamsikrishna Gunnam M.B.B.S [2]
Overview
The mainstay of treatment for blue rubber bleb nevus syndrome is interferon-beta, octreotide, iron supplementation and blood transfusions.
Medical Therapy
- Pharmacologic medical therapies for blue rubber bleb nevus syndrome include:[1][2][3][4][5]
- Preferred regimen (1):Interferon-beta, 1.2 mg/m2/day for 2 months
- Preferred regimen (2):Octreotide, 5.7 microg/kg subcutaneously twice daily for 4 weeks[6]
- Preferred regimen (3):Sirolimus [7]
- Preferred regimen (4):Iron supplementation
- Preferred regimen (5):Blood transfusions
- Preferred regimen (6):Corticosteroids
- Preferred regimen (7):Propranolol
- Preferred regimen (8):Thalidomide
|
Blue rubber bleb nevus syndrome Microchapters |
|
Differentiating Blue Rubber Bleb Nevus Syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Blue rubber bleb nevus syndrome medical therapy On the Web |
|
American Roentgen Ray Society Images of Blue rubber bleb nevus syndrome medical therapy |
|
Directions to Hospitals Treating Blue rubber bleb nevus syndrome |
|
Risk calculators and risk factors for Blue rubber bleb nevus syndrome medical therapy |
References
- ↑ Agnese M, Cipolletta L, Bianco MA, Quitadamo P, Miele E, Staiano A (April 2010). "Blue rubber bleb nevus syndrome". Acta Paediatr. 99 (4): 632–5. doi:10.1111/j.1651-2227.2009.01608.x. PMID 19958301.
- ↑ Jain A, Kar P, Chander R, Khandpur S, Jain S, Prabhash K, Gangwal P (1998). "Blue rubber bleb nevus syndrome: a cause of gastrointestinal hemorrhage". Indian J Gastroenterol. 17 (4): 153–4. PMID 9795507.
- ↑ Jin, Xue-Li (2014). "Blue rubber bleb nevus syndrome: A case report and literature review". World Journal of Gastroenterology. 20 (45): 17254. doi:10.3748/wjg.v20.i45.17254. ISSN 1007-9327.
- ↑ Boente, Maria del C.; Cordisco, Maria R.; Frontini, Maria del V.; Asial, Raul A. (1999). "Blue Rubber Bleb Nevus (Bean Syndrome): Evolution of Four Cases and Clinical Response to Pharmacologic Agents". Pediatric Dermatology. 16 (3): 222–227. doi:10.1046/j.1525-1470.1999.00065.x. ISSN 0736-8046.
- ↑ Ogu, Ugochi O.; Abusin, Ghada; Abu-Arja, Rolla F.; Staber, Janice M. (2018). "Successful Management of Blue Rubber Bleb Nevus Syndrome (BRBNS) with Sirolimus". Case Reports in Pediatrics. 2018: 1–5. doi:10.1155/2018/7654278. ISSN 2090-6803.
- ↑ Gonzalez D, Elizondo BJ, Haslag S, Buchanan G, Burdick JS, Guzzetta PC, Hicks BA, Andersen JM (August 2001). "Chronic subcutaneous octreotide decreases gastrointestinal blood loss in blue rubber-bleb nevus syndrome". J. Pediatr. Gastroenterol. Nutr. 33 (2): 183–8. PMID 11568521.
- ↑ Ünlüsoy Aksu A, Sari S, Eğritaş Gürkan Ö, Dalgiç B (March 2017). "Favorable Response to Sirolimus in a Child With Blue Rubber Bleb Nevus Syndrome in the Gastrointestinal Tract". J. Pediatr. Hematol. Oncol. 39 (2): 147–149. doi:10.1097/MPH.0000000000000681. PMID 27820137.